Back to Search Start Over

argenx to Present at Upcoming Investor Conferences

Source :
GlobeNewswire. November 1, 2023
Publication Year :
2023

Abstract

November 1, 2023 Amsterdam, the Netherlands - argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.771015061